跳至主要内容
临床试验/NCT03603418
NCT03603418Unknown4 期

Role Of Dexamethasone In Induction Of Labor : A Randomized Clinical Trial .

Ain Shams University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年7月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
80
试验地点
1
主要终点
Induction delivery interval

研究概览

简要总结

Research hypothesis :

In pregnant women undergoing induction of labor, intramuscular injection of dexamethasone may accelerate induction delivery interval.

Research question :

In pregnant women undergoing induction of labor, does intramuscular injection of dexamethasone accelerate induction delivery interval ?

This study aims to assess the effect of intramuscular administration of dexamethasone on the induction delivery interval in full term patients undergoing induction of labor.

详细描述

The use of corticosteroids is one of the methods put forward for the strengthening and speeding up the process of labor. After identification of glucocorticoid receptors in human amnion, the role of corticosteroids in starting the process of labor has been studied in numerous studies. Some of them discussed the relation between dexamethasone injection and labor induction but still there is insufficient data. So by the end of this study it may be possible to assess the effect of intramuscular dexamethasone injection on shortening the induction delivery interval.

  • Type of Study: Randomized Clinical Double Blind Trial .
  • Study Setting: The study will be conducted at Ain Shams Maternity Hospital.
  • Study Population: Full term patients who attend to the labor ward in El Demerdash Maternity Hospital and scheduled for induction of labor.
  • Sample Size: Sample size was calculated using PASS® version 15.0, setting the power (β) at 0.02 and the significance level (α) at 0.05. Data from previous reports (Kashanian et al., 2008) indicated that mean Induction-Active phase Interval in women receiving 8mg of dexamethasone before induction of labor and controls was 3.09±1.5 and 4.21±1.8 hours respectively. Calculation according to these values produced a minimal sample size of 70 patients to be randomized equally to both groups. Assuming a drop-out rate of 15%, a minimum drop-out inflated enrollment sample size of approximately 80 women will be needed.
  • Ethical Considerations: The study will be approved from the Ethical Committee of the Department of Obstetrics and Gynecology, Faculty of Medicine, Ain Shams University. Informed written consent will be taken from all women before recruitment in the study, and after extensive explanation and clear discussion of risks and benefits.
  • Study Procedures: A total of 80 women undergoing induction of labor will be included in this study after taking their consent for this clinical trial after full explanation of the trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

性别
Female
接受健康志愿者

入选标准

  • Gestational age (39-41) weeks according to Naegele's rule and a first-trimester ultrasound evaluation.
  • Vertex presentation.
  • Singleton fetus.
  • Intact fetal membranes.
  • No contraindication for vaginal delivery.
  • Cervix with a poor Bishop score (4-6).
  • Reactive CTG.
  • Average amount of liquor.

排除标准

  • Indication for cesarean section e.g. CPD, Placenta previa, IUGR, Non vertex presentation and previous cesarean section.
  • Maternal medical disorders as diabetes mellitus and severe pre-eclampsia.
  • Active phase of labor (cervical dilatation of 4 cm plus 3 forceful contractions over a ten minute span).
  • Preterm labor and premature rupture of membranes.
  • Multiparous women.
  • Significant vaginal bleeding. Placenta previa, probable placental abruption.
  • Fetal macrosomia>4.5 kg estimated by u/s.
  • Multiple pregnancy.
  • Fetal Distress and Non-reactive CTG.
  • Oligohydramnios.

研究组 & 干预措施

Group D (Study group-Dexamethasone group)

Experimental

Forty patients undergoing induction of labor will receive 8 mg (2ml) of the product dexamethasone sodium phosphate intramuscular one hour before the initiation of labor induction in the form of epidrone ampoules which is a dexamethasone product from Epico-Egypt, and labor induction will be performed according to the American College of Obstetricians and Gynecologists protocol, i.e, starting by 25 mcg of PGE1 vaginally, in the form of Vagiprost, every 3-6 hours according to patient response, Dexamethasone will be given one hour before the first dose of Vagiprost, when bishop score reaches 6 to 8, oxytocin will be added by 5 drops/minute of 500 cc saline + 5 units of oxytocin with the dose increasing by 5-10 drops / minute every 30 minute till optimal contractions are reached which are three uterine contractions in 10 minutes and each lasting for 40-50 seconds

干预措施: Dexamethasone Sodium Phosphate (Drug)

Group C (Control group)

Placebo Comparator

Forty patients undergoing induction of labor will receive 2ml of distilled water intramuscular one hour before the initiation of labor induction, and labor induction will be performed by the same protocol as above.

干预措施: Distilled water (Other)

结局指标

主要结局

Induction delivery interval

时间窗: It may vary from 4 to 6 hours up to 72 hours

The time between beginning of the induction of labor till the end of the 2nd stage of labor

次要结局

  • Induction active phase interval(It may vary from 2 to 3 hours up to 48 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kareem Medhat Mohamed Abdallah

ObGyn Resident

Ain Shams University

研究点 (1)

Loading locations...

相似试验

Role Of Dexamethasone In Induction Of Labor | 临床试验